Retinal vascular events after intravitreal bevacizumab.

Purpose: To record retinal vascular events following intravitreal bevacizumab injection.

Methods: Collaborative multi-centre retrospective case series.

Results: Eight patients were documented to have central retinal artery occlusion (four patients), branch retinal artery occlusion, capillary occlusion, central retinal vein occlusion and branch retinal vein occlusion (one patient each) within 0-55 days (median 2 weeks) of intravitreal bevacizumab.

Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons.

Purpose: The rate and magnitude of spontaneous visual recovery are very poor in central retinal vein occlusion (CRVO). In the first follow-up year, the Central Vein Occlusion Study Group reported that only 6% of eyes recovered > or = 3 lines of vision and none recovered > or = 8 lines of vision. Retinal endovascular surgery (REVS) is vitrectomy followed by cannulation of retinal vessels with injection of tissue plasminogen activator.

Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults.

Purpose: To report the results of retinal endovascular surgery and intravitreal triamcinolone acetonide on two eyes of two patients younger than 40 years of age with central vein occlusion.

Design: Interventional case reports from a study approved by the Institutional Review Board of North Broward Medical Center, Pompano Beach, Florida.

Methods: Two men, ages 37 and 39, with unilateral central vein occlusion were treated with retinal endovascular surgery and intravitreal triamcinolone acetonide.